Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
SAR131675: VEGFR-3 Inhibitor Assay Guide
2026-09-28
A practical, evidence-based guide to using SAR131675 (SKU B2301) in VEGFR-3 pathway and cell-response assays. It covers potency benchmarks, formulation constraints, interpretation, and the limits of translating preclinical findings into new models.
-
Arachidonic Acid: From Lipid Pool to Antibody Response
2026-09-27
Arachidonic Acid is more than an inflammatory substrate: its location, metabolism, and timing can shape immune readouts. This article examines new evidence linking arachidonic acid to humoral immunity and translates it into practical, compartment-aware assay decisions.
-
CCCP as a Stress-Test for Mitochondrial Biomarkers
2026-09-26
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) can help researchers probe how mitochondrial energy stress relates to cell morphology. This article connects its protonophore mechanism with a deep-learning study of urine-derived stem cells—and explains why that study does not establish CCCP as a diagnostic test.
-
From Guanine Accessibility to Genome Integrity
2026-09-25
N3-kethoxal offers a click-compatible way to capture accessible guanines in RNA and single-stranded DNA. This article considers how that structural information can support translational studies of genome integrity—while distinguishing accessibility mapping from direct detection of DNA lesions or R-loops.
-
(-)-JQ1 in PDA: Interpreting BET Biology
2026-09-25
Learn how the JQ1 stereoisomer (-)-JQ1 can help distinguish BET-related effects from reporter responses in pancreatic cancer experiments. This article connects a pancreatic ductal adenocarcinoma screening study to practical assay design, controls, and interpretation limits.
-
DiR for Cell Tracking in Neurocognitive Research
2026-09-24
DiR (DiIC 18 (7)) can help researchers follow labeled cells in vivo while investigating neuroprotective strategies such as hUC-MSC treatment after surgery. This practical workflow explains how to pilot membrane labeling, distinguish cell-associated signal from biological mechanism, and troubleshoot near-infrared imaging.
-
Cytochalasin B (NSC 107658) in Actin Research
2026-09-24
Cytochalasin B (NSC 107658) is an actin-disrupting research compound used to examine cytoskeleton-dependent cell behavior. Product information describes its action at actin-filament barbed ends, while a peer-reviewed S2-cell study reports reduced Spiroplasma eriocheiris infection after cytochalasin B treatment.
-
Coumestrol-Driven Ferroptosis in Rheumatoid Arthritis FLS
2026-09-23
A 2026 study reports that Coumestrol suppresses proliferation and inflammatory cytokine production in an RA fibroblast-like synoviocyte model while promoting PMAIP1-associated ferroptosis. The proposed mechanism links reduced TRIM3-mediated PMAIP1 degradation to increased PMAIP1 protein stability, although validation beyond the cell model is needed.
-
EdU Flow Cytometry Assay Kits (Cy3): Workflow
2026-09-23
Turn a short EdU pulse into a quantitative S-phase readout for cancer pharmacology, cell-cycle studies, and genotoxicity testing. The Cy3 click-chemistry workflow avoids DNA denaturation, preserving compatibility with surface, intracellular, and cell-cycle markers.
-
Cy3 Maleimide: Thiol Labeling for Repair Assays
2026-09-22
Cy3 maleimide converts accessible cysteines, thiol-modified oligonucleotides, and functionalized nanoparticle surfaces into trackable fluorescent targets. Its non-sulfonated format is especially useful for controlled in vitro labeling, replication-stress models, and fluorescence microscopy imaging when solvent handling and thiol accessibility are carefully managed.
-
(R)-MG132: A Rigorous Proteasome Control
2026-09-22
Learn how (R)-MG132 (SKU C3348) strengthens proteasome inhibition validation, cell-based assays, and mechanistic studies. This scenario-driven guide covers stereochemical controls, handling, data interpretation, and practical product selection.
-
3-Methyladenine: Mechanism and Research Use
2026-09-21
3-Methyladenine, also called 3-MA, is a research inhibitor that modulates class III PI3K and autophagy-related signaling. Its dual temporal effects on class I and class III PI3K make it useful for autophagy research, but those same effects limit interpretation as a pathway-specific reagent.
-
MOG (35-55) for EAE Research Workflows
2026-09-21
MOG (35-55) provides a defined antigen system for reproducible experimental autoimmune encephalomyelitis, from induction studies to pathway-focused neuroinflammation assays. Its handling range and compatibility with mechanistic endpoints make it useful for connecting disease scores with emerging STAT1/STAT2 and type I interferon biology.
-
Cytochalasin B: From Actin Mechanism to Translation
2026-09-20
Cytochalasin B, also known as NSC 107658, offers translational researchers a reversible way to test whether actin remodeling drives cellular entry, motility, division, and transport. By connecting its barbed-end mechanism with evidence from Spiroplasma eriocheiris infection in Drosophila S2 cells, this article presents a practical framework for converting cytoskeletal perturbation into stronger pathway and drug-discovery decisions.
-
Zwitterionic Lipids Improve mRNA Cancer Vaccines
2026-09-19
The reference study describes a membrane-destabilizing zwitterionic lipid with a pH-responsive PyCB headgroup that improves mRNA expression in lymph-node antigen-presenting cells while reducing local LNP reactogenicity in mice. Its results support rational lipid design as a way to balance endosomal escape, antigen presentation, antitumor immunity, and tolerability, although clinical translation remains unresolved.